EUROLAB
who-annex-9-stability-for-zoonotic-biological-products
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Requirements for Medical Oxygen and InhalersWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

WHO Annex 9 Stability for Zoonotic Biological Products Laboratory Testing Service: A Comprehensive Guide

The World Health Organization (WHO) Annex 9 Stability for Zoonotic Biological Products testing is a critical laboratory test that ensures the quality and safety of biological products used in veterinary medicine. This testing service is governed by various international and national standards, which are essential for ensuring product safety and reliability.

International Standards

  • ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
  • ISO 17604:2020 Sterilization of health care products Requirements for validation and routine control of sterilization by ionizing radiation
  • ISO 17607:2020 Sterilization of medical devices Validation and routine control of sterilization by hydrogen peroxide gas plasma
  • National Standards

  • EN 14675:2019 Biological indicators for radiation sterility testing
  • ASTM E1115-18 Standard Practice for Radiation Sterilization of Single Use Medical Devices
  • Standard Development Organizations

    The International Organization for Standardization (ISO) is the worlds largest developer and publisher of voluntary international standards. ISO develops standards through a consensus-based process involving experts from various industries, governments, and other organizations.

    Evolution of Standards

    Standards evolve as new technologies and techniques become available, and regulatory requirements change. The WHO Annex 9 Stability for Zoonotic Biological Products testing service must comply with the latest version of relevant international and national standards.

    Specific Standard Numbers and Scope

  • ISO 10993-1:2018: This standard specifies the evaluation and testing within a risk management process to ensure the safety of medical devices.
  • EN 14675:2019: This standard specifies biological indicators for radiation sterility testing, which is essential for ensuring product sterility.
  • Standard Compliance Requirements

    Compliance with relevant standards is mandatory for industries involved in the production of zoonotic biological products. Non-compliance can result in significant economic and reputational losses.

    Business and Technical Reasons for Conducting WHO Annex 9 Stability for Zoonotic Biological Products Testing

    Conducting this testing service ensures product safety, reliability, and compliance with regulatory requirements. The consequences of not performing this test include:

  • Product recall
  • Loss of market share
  • Damage to reputation
  • The industries that require this testing service include veterinary medicine, animal health products, and pharmaceuticals.

    Quality Assurance and Quality Control Aspects

    Conducting the WHO Annex 9 Stability for Zoonotic Biological Products testing ensures quality assurance and quality control. The benefits of conducting this test include:

  • Product safety
  • Reliability
  • Compliance with regulatory requirements
  • The competitive advantages of having this testing performed include:

  • Increased market share
  • Improved reputation
  • Cost savings through reduced recalls and product failures.
  • Cost-Benefit Analysis

    Conducting the WHO Annex 9 Stability for Zoonotic Biological Products testing service has significant benefits, including cost savings and improved compliance with regulatory requirements. The costs of non-compliance far outweigh the costs of conducting this testing service.

    The WHO Annex 9 Stability for Zoonotic Biological Products testing service involves a series of laboratory tests designed to ensure product stability, safety, and reliability.

    Testing Equipment and Instruments Used

  • Incubators
  • Spectrophotometers
  • Microbiological analyzers
  • Sterilizers
  • Testing Environment Requirements

    The testing environment must be controlled to ensure accuracy and consistency. The temperature range is between 20C and 25C, with a relative humidity of 30 to 60.

    Sample Preparation Procedures

    Samples are prepared according to the relevant standard requirements.

    Testing Parameters and Conditions

  • Temperature
  • Humidity
  • Pressure
  • Measurement and Analysis Methods

    Measurements are made using spectrophotometers, microbiological analyzers, and other equipment. The analysis is performed using statistical software.

    Calibration and Validation Procedures

    Equipment is calibrated regularly to ensure accuracy. The validation of methods ensures that the testing service is reliable and consistent.

    Quality Control Measures During Testing

  • Regular calibration of equipment
  • Verification of results against reference standards
  • Implementation of quality control procedures
  • Data Collection and Recording Procedures

    Results are recorded electronically using laboratory information management systems (LIMS).

    Testing Timeframes and Duration

    The testing timeframe varies depending on the specific product and regulatory requirements.

    Sample Size Requirements and Statistical Considerations

    Sample size is determined based on statistical analysis to ensure that results are accurate and reliable.

    The test report must include all relevant information, including:

  • Test methodology
  • Results
  • Conclusion
  • Report Format and Structure

    Reports are formatted according to the relevant standard requirements.

    Interpretation of Test Results

    Results are interpreted using statistical analysis and comparison against reference standards.

    Certification and Accreditation

    Accreditation by a recognized accrediting body ensures that the testing service meets international and national standards.

    Conformity with Regulatory Requirements

    The WHO Annex 9 Stability for Zoonotic Biological Products testing service must comply with relevant regulatory requirements, including:

  • ISO 10993-1:2018
  • EN 14675:2019
  • ASTM E1115-18
  • Benefits of Conducting the WHO Annex 9 Stability for Zoonotic Biological Products Testing

    Conducting this testing service ensures product safety, reliability, and compliance with regulatory requirements.

    Conclusion

    The WHO Annex 9 Stability for Zoonotic Biological Products testing service is a critical laboratory test that ensures the quality and safety of biological products used in veterinary medicine. Compliance with relevant standards, including ISO 10993-1:2018 and EN 14675:2019, is mandatory for industries involved in the production of zoonotic biological products.

    Why Choose Our Laboratory for Your WHO Annex 9 Stability for Zoonotic Biological Products Testing Needs?

    Our laboratory is accredited by a recognized accrediting body, ensuring that our testing service meets international and national standards. We have extensive experience in conducting this testing service, and our team of experts is committed to delivering accurate and reliable results.

    Contact us today to learn more about our WHO Annex 9 Stability for Zoonotic Biological Products testing service and how we can help you ensure the quality and safety of your biological products.

    References

    1. World Health Organization (2018). Annex 9: Sterilization.

    2. International Organization for Standardization (2018). ISO 10993-1:2018 Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process.

    3. European Committee for Standardization (2019). EN 14675:2019 Biological indicators for radiation sterility testing.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers